by Clinical Neuropsychologist Online | Wednesday, July 10, 2024 | Dementia
Abstract BACKGROUND Previous studies have found that Alzheimer’s disease (AD)-related plasma markers are associated with amyloid beta (Aβ) deposition, but the change of this association in different Aβ pathological stages remains unclear. METHODS Data were...
by Clinical Neuropsychologist Online | Wednesday, July 10, 2024 | Dementia
Abstract INTRODUCTION Although frontotemporal dementia (FTD) with right anterior temporal lobe (RATL) predominance has been recognized, a uniform description of the syndrome is still missing. This multicenter study aims to establish a cohesive clinical phenotype....
by Clinical Neuropsychologist Online | Wednesday, July 10, 2024 | Dementia
Abstract INTRODUCTION Evidence has emerged that cardiometabolic multimorbidity (CMM) is associated with dementia, but the underlying mechanisms are poorly understood. METHODS This population-based study included 5704 older adults. Of these, data were available in 1439...
by Clinical Neuropsychologist Online | Tuesday, July 9, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Hui‐Chin Chang, Ru‐Yin Tsai, Chen‐Pi Li, Wen‐Chieh Liao,...
by Clinical Neuropsychologist Online | Monday, July 8, 2024 | Dementia
Abstract INTRODUCTION More robust non-human primate models of Alzheimer’s disease (AD) will provide new opportunities to better understand the pathogenesis and progression of AD. METHODS We designed a CRISPR/Cas9 system to achieve precise genomic deletion of...
